The potential of metabolomics
Metabolomics It is a scientific discipline that studies the metabolites, the small molecules produced by biological processes. These compounds offer a faithful image of the physiological state of an organism, revealing important diagnostic information and therapeutic. In recent years, this science has assumed a fundamental role in fields such as personalized medicine, early diagnosis of diseases and monitoring the effectiveness of treatments. Thanks to its ability to precisely analyze a patient’s biochemical profile, metabolomics is considered a key tool for discovering biomarkers useful in the fight against complex diseases such as tumors and neurodegenerative diseases.
Artificial intelligence in biomedical research
The integration of Artificial Intelligence (AI) in metabolomics marked a turning point. Algorithms of Machine Learning are now able to analyze large amounts of metabolic data, recognize hidden patterns and build predictive models useful in the diagnosis and classification of diseases. Techniques such as Random Forest, Support Vector Machine And neural networks They are used to select the most relevant information from huge datasets. This synergy between AI and metabolomics has accelerated the discovery of biomarkers in many diseases, including breast cancer, Alzheimer, diabetes And COVID-19, with potential applications across precision medicine.
A growing scientific community
From 2017 to 2022 there has been a rapid growth in the number of scientific publications on the topic, with United States, China And Germany among the major contributors. Major universities, such as the University of California system And Harvard, and reference magazines such as Metabolites And Scientific Reports, have contributed significantly to the development of the sector. Bibliometric analysis has identified recurring keywords such as “identification,” “diagnosis,” and “mass spectrometry,” highlighting the global interest in the use of AI in metabolomics. Future prospects point toward the integration of “multi-omics” data and the development of Explainable AI, capable of providing results that can also be interpreted by clinicians. This new approach promises to radically transform biomedical research, improving understanding of molecular mechanisms of diseases and guiding new therapeutic strategies.
For further information: Kopeć KK, Cannas F, Piras C, Spada M, Noto A, Atzori L, Fanos V. Unlocking the secrets of metabolomics with Artificial Intelligence: a comprehensive literature review. J Pediatr Neonat Individual Med. 2024;13(1):e130105. doi: 10.7363/130105.